神经血管导管市场 - 全球产业规模、份额、趋势、机会及预测（按类型、应用、组件、最终用户、地区和竞争格局划分），2021-2031年

全球神经血管导管市场预计将从 2025 年的 35.4 亿美元成长到 2031 年的 54.1 亿美元，复合年增长率为 7.32%。

这些专用医疗设备对于探索复杂的脑血管系统、诊断和治疗颅内动脉瘤和缺血性中风等疾病至关重要。市场成长的主要驱动力是全球脑血管疾病发生率的上升趋势，以及对微创血管内治疗技术的强劲需求，因为与传统开放性手术相比，微创血管内治疗技术能够提供更快的復健。最新统计数据也印证了这项需求：根据世界中风组织（WSO）预测，到2024年，全球将新增约1,200万例中风病例，凸显了高效介入治疗的迫切性。

然而，由于产品研发成本高昂以及III类医疗设备监管核准流程严格，市场面临许多障碍。这些财务和行政方面的障碍会延缓新技术的推广应用，并限制其在成本敏感发展中市场的普及。因此，製造商不得不应对复杂的报销机制和严格的合规要求，这共同阻碍了全球市场的成长。

市场驱动因素

全球神经血管导管市场的主要驱动因素是急性缺血性脑中风和脑动脉瘤发病率的不断上升，而全球人口老化进一步加剧了这一趋势。随着老龄化增长，血管健康状况下降，即时介入以预防死亡和长期残疾的需求变得愈发迫切，迫使医疗系统必须配备有效的导管设备。根据美国心臟协会于2024年1月发布的《2024年心臟病和中风统计更新》，2021年美国约有1/21的死亡病例是由中风造成的，凸显了这个问题的严重性。这项挑战是全球性的，世界卫生组织（WHO）的一项重要分析报告显示，到2021年，全球将有超过30亿人患有神经系统疾病，这为神经血管诊断创造了庞大的患者群体。

同时，微创神经血管介入手术的日益普及和持续的技术创新正在推动市场成长。由于恢復时间更短且在复杂解剖结构中导航更为便捷，医疗专业人员越来越多地选择血管内治疗方法而非开放性手术。为此，製造商正在开发先进的抽吸和通路导管，以提高手术的安全性和有效性。这种向先进介入工具的转变正在为主要市场参与企业带来显着的收入成长。例如，Penumbra公司在2024年2月报告称，其截至2023年12月31日的财年全球血栓切除产品收入将达到6.773亿美元，比上年增长32.5%，这充分体现了技术创新如何推动市场扩张。

市场挑战

高昂的产品研发成本，加上严格的监管核准程序，对全球神经血管导管市场的成长构成了重大障碍。这些导管被归类为III类医疗设备，必须接受严格的监管审查，需要进行耗资巨大且大规模的临床试验，以证明其在脆弱的脑血管中的安全性和有效性。这种严格的上市前流程延长了研发週期，并给资金不足但具有创新精神的中小型企业造成了巨大的财务障碍。因此，该行业仍然由少数几家大型企业主导，削弱了价格竞争，并减缓了新技术的引入。

此外，严峻的监管环境迫使企业将大量资源从创新转移到合规和认证维护。近期行业数据显示，满足这些标准带来的日益沉重的财务负担：根据欧洲医疗技术协会 (MedTech Europe) 2025 年的一项调查，医疗设备製造商预计，未来五年内，与监管维护和重新认证相关的成本将增加 50%。不断上涨的营运成本迫使製造商优先考虑成熟的、高回报的市场以获得投资回报，而忽略了对价格敏感、中风发病率不断上升的发展中地区。这种情况有效地限制了市场的整体覆盖范围，并抑制了全球成长速度。

市场趋势

为了克服手动操作导管的局限性，市场正日益采用机器人辅助系统。这些系统在复杂的神经血管手术中提供卓越的稳定性和精准度，能够实现亚毫米级的器械控制，显着降低血管损伤的风险，并为远距介入治疗开闢了道路。远端机器人技术的转变使专家能够远端进行手术，有助于缓解医疗资源匮乏地区介入神经放射学短缺的问题。例如，2024年12月，MicroRobot Medical公司宣布成功完成了一项模拟远距手术，手术地点相距五英里，在向FDA提交申请之前，就已证明了远距血管内手术的技术可行性。

同时，由于直接抽吸首过技术（ADAPT）能够快速有效地重组，临床医师正将其作为机械取栓的主要方法。这种转变推动了对大口径抽吸导管的需求，这些导管的设计旨在提供强大的吸力以清除血栓。由于医生更倾向于使用这些专用器械而非传统的血栓摘取支架来治疗急性缺血性脑中风，製造商在该领域正经历着强劲的成长。根据史赛克公司2025年1月发布的报告，该公司医疗外科和神经技术部门2024财年全年净销售额预计将增长11.1%，显示市场对先进介入神经放射学技术的需求将持续旺盛。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球神经血管导管市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依类型（微导管、球囊导管、通路导管、栓塞导管、其他）
  • 依应用领域（细胞栓塞、脑动脉瘤、动静脉畸形等）
  • 依组件分类（导管芯轴、导管衬里、回流焊接热缩管、尼龙管/Pebax、其他）
  • 依最终使用者（医院/诊所、门诊手术中心、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美神经血管导管市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲神经血管导管市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区神经血管导管市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲神经血管导管市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲神经血管导管市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球神经血管导管市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Medtronic plc
• Stryker Corporation
• Johnson & Johnson
• Penumbra, Inc.
• Terumo Corporation
• MicroVention, Inc.
• Integer Holdings Corporation
• Boston Scientific Corporation
• Asahi Intecc Co., Ltd.
• B. Braun Melsungen AG

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Neurovascular Catheters Market is projected to expand from USD 3.54 Billion in 2025 to USD 5.41 Billion by 2031, registering a CAGR of 7.32%. These specialized medical instruments are essential for navigating complex cerebral vasculature to diagnose and treat disorders like intracranial aneurysms and ischemic strokes. Market momentum is primarily fueled by the growing global burden of cerebrovascular diseases and a strong preference for minimally invasive endovascular techniques, which offer faster recovery than traditional open surgeries. Recent statistics underscore this demand; according to the World Stroke Organization, approximately 12 million new stroke cases were documented worldwide in 2024, emphasizing the urgent necessity for efficient interventional therapies.

However, the market encounters substantial hurdles due to the exorbitant costs associated with product development and the rigorous regulatory approval frameworks mandated for these Class III medical devices. Such financial and bureaucratic obstacles can postpone the release of new technologies and restrict their availability in cost-sensitive developing markets. As a result, manufacturers are compelled to manage intricate reimbursement structures and strict compliance requirements, which collectively hinder the speed of global market growth.

Market Driver

The principal factor propelling the Global Neurovascular Catheters Market is the increasing prevalence of acute ischemic strokes and cerebral aneurysms, a trend aggravated by the aging global population. As vascular health declines with age, the need for immediate interventions to avert mortality and long-term disability becomes more critical, compelling healthcare systems to secure effective catheterization devices. Data from the American Heart Association's '2024 Heart Disease and Stroke Statistics Update' in January 2024 indicates that stroke caused roughly 1 out of every 21 deaths in the United States in 2021, highlighting the severity of the issue. This challenge is widespread; a major 2024 analysis by the World Health Organization reported that over 3 billion individuals globally were living with a neurological condition in 2021, creating a massive patient base for neurovascular diagnostics.

Concurrently, market growth is bolstered by the rising utilization of minimally invasive neuroendovascular procedures and ongoing technological innovation. Medical professionals are increasingly favoring endovascular methods over open surgery because of shorter recovery periods and better navigation through tortuous anatomies. In response, manufacturers are creating advanced aspiration and access catheters to improve procedural safety and effectiveness. This pivot toward sophisticated interventional tools is yielding significant revenue growth for major industry participants. For example, Penumbra, Inc. reported in February 2024 that revenue from their global thrombectomy products reached $677.3 million for the year ending December 31, 2023, a 32.5% increase from the previous year, demonstrating how innovation drives market expansion.

Market Challenge

The combination of high product development costs and stringent regulatory approval procedures presents a major obstacle to the growth of the Global Neurovascular Catheters Market. Categorized as Class III medical devices, these catheters face intense regulatory scrutiny, requiring expensive and extensive clinical trials to prove their safety and efficacy within fragile cerebral blood vessels. This demanding pre-market process creates a significant financial hurdle that extends development timelines and deters smaller, innovative companies lacking sufficient capital. Consequently, the industry remains dominated by a handful of large corporations, which diminishes competitive pricing dynamics and decelerates the launch of new technologies.

Furthermore, this difficult regulatory landscape forces companies to divert essential resources from innovation to compliance and certification maintenance. The growing financial strain of meeting these standards is highlighted by recent industry data; according to a 2025 survey by MedTech Europe, medical device manufacturers anticipate a 50% rise in costs associated with regulatory maintenance and re-certification over a five-year period. These increasing operational costs compel manufacturers to prioritize established, high-margin markets to recoup their investments, often neglecting price-sensitive developing regions where stroke prevalence is rising. This situation effectively limits the market's total reach and suppresses global growth rates.

Market Trends

The market is increasingly adopting robotic-assisted systems to mitigate the constraints of manual catheter navigation, providing superior stability and precision during intricate neurovascular surgeries. This technology enables sub-millimeter accuracy in device control, drastically lowering the risk of vessel damage while opening possibilities for remote interventions. The move toward telerobotics helps address the shortage of neurointerventional specialists in underserved areas by allowing experts to perform procedures from distinct locations. For instance, in December 2024, Microbot Medical announced the successful completion of a simulated telesurgery between two sites five miles apart, confirming the technical viability of remote endovascular operations ahead of their FDA submission.

Simultaneously, clinicians are standardizing the Direct Aspiration First Pass Technique (ADAPT) as a primary method for mechanical thrombectomy due to its rapid and effective revascularization capabilities. This shift is fueling demand for large-bore aspiration catheters engineered with maximized inner lumens to provide powerful suction for clot removal. As physicians favor these specialized tools over conventional stent retrievers for treating acute ischemic stroke, manufacturers are seeing strong growth in this segment. According to Stryker's January 2025 report, net sales for their MedSurg and Neurotechnology segment rose by 11.1% for the full year 2024, indicating sustained demand for advanced neurointerventional technologies.

Key Market Players

• Medtronic plc
• Stryker Corporation
• Johnson & Johnson
• Penumbra, Inc.
• Terumo Corporation
• MicroVention, Inc.
• Integer Holdings Corporation
• Boston Scientific Corporation
• Asahi Intecc Co., Ltd.
• B. Braun Melsungen AG

Report Scope

In this report, the Global Neurovascular Catheters Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Neurovascular Catheters Market, By Type

• Microcatheters
• Balloon Catheters
• Access Catheters
• Embolization Catheters
• Others

Neurovascular Catheters Market, By Application

• Cell Embolic Stroke
• Brain Aneurysms
• Arteriovenous Malformations
• Others

Neurovascular Catheters Market, By Component

• Catheter Mandrels
• Catheter Liners
• Reflow Heat Shrinks
• Nylon Tubing/Pebax
• Others

Neurovascular Catheters Market, By End User

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

Neurovascular Catheters Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Neurovascular Catheters Market.

Available Customizations:

Global Neurovascular Catheters Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Neurovascular Catheters Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Microcatheters, Balloon Catheters, Access Catheters, Embolization Catheters, Others)
  • 5.2.2. By Application (Cell Embolic Stroke, Brain Aneurysms, Arteriovenous Malformations, Others)
  • 5.2.3. By Component (Catheter Mandrels, Catheter Liners, Reflow Heat Shrinks, Nylon Tubing/Pebax, Others)
  • 5.2.4. By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Neurovascular Catheters Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Component
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Neurovascular Catheters Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Component
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Neurovascular Catheters Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Component
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Neurovascular Catheters Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Component
      • 6.3.3.2.4. By End User

7. Europe Neurovascular Catheters Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Component
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Neurovascular Catheters Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Component
      • 7.3.1.2.4. By End User
  • 7.3.2. France Neurovascular Catheters Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Component
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Neurovascular Catheters Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Component
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Neurovascular Catheters Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Component
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Neurovascular Catheters Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Component
      • 7.3.5.2.4. By End User

8. Asia Pacific Neurovascular Catheters Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Component
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Neurovascular Catheters Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Component
      • 8.3.1.2.4. By End User
  • 8.3.2. India Neurovascular Catheters Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Component
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Neurovascular Catheters Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Component
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Neurovascular Catheters Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Component
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Neurovascular Catheters Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Component
      • 8.3.5.2.4. By End User

9. Middle East & Africa Neurovascular Catheters Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Component
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Neurovascular Catheters Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Component
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Neurovascular Catheters Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Component
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Neurovascular Catheters Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Component
      • 9.3.3.2.4. By End User

10. South America Neurovascular Catheters Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Component
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Neurovascular Catheters Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Component
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Neurovascular Catheters Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Component
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Neurovascular Catheters Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Component
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Neurovascular Catheters Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic plc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Stryker Corporation
• 15.3. Johnson & Johnson
• 15.4. Penumbra, Inc.
• 15.5. Terumo Corporation
• 15.6. MicroVention, Inc.
• 15.7. Integer Holdings Corporation
• 15.8. Boston Scientific Corporation
• 15.9. Asahi Intecc Co., Ltd.
• 15.10. B. Braun Melsungen AG

16. Strategic Recommendations

17. About Us & Disclaimer